James D. Chambers ( jchambers@tuftsmedicalcenter. org ) is an investigator in the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and an associate professor of medicine in the School of Medicine, Tufts University, both in Boston, Massachusetts.
Ari D. Panzer is a research assistant in the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center.
Health Aff (Millwood). 2019 Nov;38(11):1882-1886. doi: 10.1377/hlthaff.2019.00201.
We found wide variation in the evidence that US commercial health plans reported reviewing in their specialty drug coverage policies. There was little consistency in the numbers or types of studies cited by health plans. On average, only 15 percent of health plans' coverage policies cited the same study evaluating a specific drug for a specific indication.
我们发现，美国商业健康计划在其专科药物保险政策中报告审查的证据存在很大差异。健康计划引用的研究数量和类型几乎没有一致性。平均而言，只有 15%的健康计划的保险政策引用了评估特定药物用于特定适应症的相同研究。
